Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	302.94B
Revenue (ttm)	588.83B
Net Income (ttm)	35.53B
Shares Out	11.81M
EPS (ttm)	2,821.09
PE Ratio	9.09
Forward PE	n/a
Dividend	660.00 (2.57%)
Ex-Dividend Date	Mar 28, 2025

Volume	20,788
Average Volume	17,146
Open	25,650
Previous Close	25,400
Day's Range	25,200 - 25,900
52-Week Range	21,800 - 38,200
Beta	0.25
RSI	50.88
Earnings Date	Feb 13, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2023, Huons's revenue was 552.01 billion, an increase of 12.11% compared to the previous year's 492.39 billion. Earnings were 50.47 billion, an increase of 124.88%.